2011 AHA Guidelines Update
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation. Read it on the web or download the PDF.
Metabolic profiling early in life predicts subclinical atherosclerosis
June 30, 2011 | Michael O'Riordan
Gothenburg, Sweden - A study designed to assess whether metabolic profiling provides any value beyond conventional lipid measurements suggests the metabolomics model can better stratify young patients at risk for the development of atherosclerosis.
"Atherosclerosis is characterized by a long, progressive, symptom-free period, and the extent of atherosclerosis can be measured in the subclinical state using ultrasound sonography, for instance, of the carotid artery," said lead investigator Dr Peter Würtz (University of Helsinki, Finland). "Carotid atherosclerosis as measured by ultrasound is a strong predictor of cardiovascular events. The aim of our study was to do comprehensive metabolic profiling to see whether we can determine who will develop increased carotid intima-media thickness [IMT] later in life." Read the article at TheHeart.org
Varenicline may raise CV events in CVD patients: FDA
June 16, 2011 | Michael O'Riordan
The smoking-cessation drug varenicline (Chantix, Pfizer) may be associated with a small increased risk of cardiovascular events in patients with cardiovascular disease, according to the Food and Drug Administration. Read the article at TheHeart.org
Regular exercise slows atherosclerosis progression
June 15, 2011 | Nancy Melville
Regular physical activity remains the key to the prevention of atherosclerosis progression, even when patients are also receiving intensive lipid and glucose management through medication and diet, according to research presented here at the American College of Sports Medicine 2011 Annual Meeting. Read the article at TheHeart.org
All trans-fatty acids linked to higher CVD mortality
April 18, 2011 | Lisa Nainggolan
Trans-fatty acids (TFAs) that occur naturally in ruminant fat and those from partially hydrogenated fish oils (PHFOs) both contribute to increased cardiovascular and coronary heart disease mortality, a new prospective study reported at the EuroPRevent 2011 meeting this past weekend shows. Read the article at TheHeart.org
Ambitious predictions as Yusuf preaches prevention
April 18, 2011 | Lisa Nainggolan
Application of a few simple principles to the entire world's population could help eliminate cardiovascular disease by 2050—this is the ambitious prediction of world-renowned cardiologist and epidemiologist Dr Salim Yusuf (McMaster University, Hamilton, ON), who gave an honorary lecture at the EuroPRevent 2011 meeting here this past weekend, to great applause. Read the article at TheHeart.org
Mediterranean diet and metabolic syndrome
March 7, 2011 | Michael O'Riordan
Athens, Greece - A diet high in monounsaturated fatty acids, fruits, vegetables, whole-grain cereals, and low-fat dairy products, coupled with fish, poultry, nuts, legumes, and a low consumption of red meat also known as the Mediterranean diet is associated with a lower prevalence and slower progression of metabolic syndrome, according to the results of a new meta-analysis. Read more on TheHeart.org
Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction
August 22/29, 2012
Cardiovascular disease is among the leading causes of morbidity and mortality worldwide. Preventive treatment of high-risk symptomatic individuals depends on accurate prediction of a person’s risk to develop a cardiovascular event. Currently, cardiovascular risk prediction in asymptomatic individuals is based on the level of cardiovascular risk factors incorporated in scoring equations. Continue reading...
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness
A Systematic Review and Meta-Analysis
October 8, 2007
Carotid intima-media thickness (IMT) is an intermediate phenotype for early atherosclerosis. Because it can be measured relatively simply and noninvasively, it is well suited for use in large-scale population studies. Ultrasonic measurements correlate well with histology, and increased IMT is associated with vascular risk factors and the presence of more advanced atherosclerosis, which includes coronary artery disease. Continue reading...